Defining standards of CARE for invasive fungal diseases in the ICU.


Cuenca-Estrella M, Kett DH, Wauters J.
J Antimicrob Chemother. 2019 Mar 1;74(Supplement_2):ii9-ii15.


The aim of this article is to review the current recommendations for the diagnosis and treatment of invasive fungal infection in the ICU setting and to explore whether there are standards of care for this patient population. The text focuses mainly on the two most common invasive fungal diseases that afflict non-neutropenic patients: candidaemia and invasive candidosis (IC), and invasive pulmonary aspergillosis (IPA).